Child psychiatric units to get extra inspections following BBC report
Extra inspections are to be carried out at children's psychiatric units following allegations about cruelty made in a BBC documentary, a government minister has revealed. Patients who were teenagers when they were admitted to Skye House, a specialist NHS unit in Glasgow, told BBC Disclosure about a culture of cruelty among nursing staff.Maree Todd, minister for mental wellbeing, told the Scottish Parliament she had requested visits and recommendations for improvements in response to the programme. "The care and treatment of young people as described in the programme are completely and wholly unacceptable," she said.
Programme-makers spoke to 28 former patients while making BBC Disclosure's Kids on The Psychiatric Ward documentary.One said the 24-bed psychiatric hospital, which sits in the grounds of Glasgow's Stobhill hospital, was like "hell".
'Institutional crisis'
On Wednesday, Meghan Gallacher, Conservative MSP for Central Scotland, asked in the Scottish Parliament how the Scottish government was responding to the programme. She said she had been supporting a family whose daughter was "illegally sectioned and brought to Skye house" where she was "subjected to abuse and neglectful care" in 2022."The abuse and cruelty that were shown in the documentary lay bare the institutional crisis at Skye house," Ms Gallacher said. "Those young women were children - children who needed our care and support."Ms Todd said the programme was a "difficult watch" and thanked the young people and their families for "having the courage to come forward".
"The cabinet secretary and I will meet NHS Greater Glasgow and Clyde as soon as possible to seek direct assurance," she said."We will also meet NHS Lothian and NHS Tayside, which host the other two adolescent units in Scotland."She said she had asked Healthcare Improvement Scotland and the Mental Welfare Commission for Scotland to carry out a series of joint visits to all adolescent in-patient units in Scotland and the national child in-patient unit. "HIS and the commission will use those visits to make recommendations on what is required to ensure the quality and safety of our child and adolescent mental health services in-patient units, both now and into the future," Ms Todd added."I will be focused on ensuring that the improvements in child and adolescent mental health services, which are clearly needed, happen as a result of our interventions."NHS Greater Glasgow and Clyde previously said a review of medication was carried out in 2023 and this changed the way medication was administered.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
2 hours ago
- Daily Record
'Investment in saving lives': Contract for alcohol and drugs crisis outreach service approved by Renfrewshire councillors
Elected members authorised senior officers to award deal to nationwide charitable organisation Change, Grow, Live. A contract for an alcohol and drugs crisis outreach service has been approved by Renfrewshire councillors in a move dubbed an "investment in saving lives". Elected members authorised senior officers to award a deal for the initiative to nationwide charitable organisation Change, Grow, Live. The step was agreed at the council's finance, resources and customer services policy board and the agreement will be for two years with an option to extend for a further year, depending on funding. The contract – which is worth almost £300,000 per annum – is anticipated to start on Friday, August 1, however, the date will be confirmed in the local authority's letter of acceptance. Councillor Graeme Clark, a Labour representative for Paisley Northeast and Ralston, said at the meeting: "Given that drug and alcohol deaths in Renfrewshire continue to be above the Scottish average and given the increasing complexity of those presenting to our services, I believe that Change, Grow, Live can provide a range of services to support individuals, families and communities that's needed. "The charity has considerable experience in working with challenging service users with complex needs including those with entrenched drug habits, offending behaviour, homelessness, antisocial behaviour, domestic violence and social deprivation." He added he has "no doubt" this funding will be an "investment in saving lives". A report, which will be considered at the meeting, explained why the matter had been brought forward to the board for consideration. It said: "The purpose of this report is to seek the approval of the finance, resources and customer services policy board to enter into a contract for Renfrewshire Alcohol and Drugs Crisis Outreach Service with Change, Grow, Live. "The provider will engage with individuals at higher risk of overdose and those who have experienced a near fatal overdose, to provide care and support, and to increase access to life-saving protective treatment. "At present, the service is delivered by the Renfrewshire Health and Social Care Partnership (HSCP) in-house harm reduction response team." Thomas Paterson, service manager for contracts and commissioning at the HSCP, said: "I agree that they come with an awful lot of experience, a significant provider of alcohol and drug services across the UK, and we're certainly excited about the skills and experience they can bring into Renfrewshire. They will be completely embedded within the alcohol and drug recovery services." The costs associated with the deal will be met by Renfrewshire Alcohol and Drug Partnership, which is a partnership consisting of the HSCP, council, Police Scotland, Scottish Fire and Rescue Service, Scottish Prison Service and voluntary sector. The maximum approved value is up to just under £900,000 for the full contract period. The agreement is for two years with the option to extend for a further year on one occasion, but the extension is fully dependent on Scottish Government funding.
Glasgow Times
2 hours ago
- Glasgow Times
Scottish firm BDD Pharma's breakthrough in drug delivery
BDD Pharma, based at BioCity Glasgow, has developed the OralogiK drug delivery system, a new tablet technology designed to release medication in the body at precisely the right time. The timed-release system could transform the way patients manage conditions that require medication at specific times, such as ADHD and rheumatoid arthritis. Read more: 'So proud': Glasgow school earns national award for STEM education. Carol Thomson, chief executive officer of BDD Pharma, said: "Currently, you take your drug when you wake up in the morning, but it takes about an hour or so to kick in. "In that period, you can't even tie your shoelaces because you're in so much pain. "So we have developed a tablet that can be taken before you go to bed. "It releases while you're asleep, at the right time before waking, and then of course you wake up pain and stiffness-free." OralogiK is already in advanced development for several treatments. The ADHD therapy is expected to become the first available next year, offering patients a once-daily tablet instead of multiple doses throughout the day. The company recently opened a new £2 million Good Manufacturing Practice (GMP) laboratory at BioCity. This facility will allow BDD to accelerate the development and production of future OralogiK and modified-release products. Carol said: "We will no longer have to outsource the scale-up, so it's going to be very much in our hands, and we will be able to keep manufacturing in Scotland, rather than sending it abroad." The new facility was funded by existing investors led by Archangels, with support from Scottish Enterprise and a new backer - the British Business Bank. To mark the opening and celebrate BDD's 25th anniversary, the company hosted a gathering at BioCity Glasgow. The BDD Pharma team (Image: Supplied) BDD currently employs more than 35 staff and expects further growth as its product pipeline advances. The company describes itself as a global drug development partner, serving clients from start-ups to major pharmaceutical firms. It has also adopted lean manufacturing principles from other industries. Calum Stevens, commercial director, said: "Traditionally, people would have to go and find someone to fix their formulation, someone to do the GMP manufacture and someone to take on the clinical work. "And they would all have minimum quantities, minimum orders, lengthy timescales and would not communicate effectively with each other,' he explained. 'So instead of that siloed approach, we offer all of this under one roof. "It means that we can move with great flexibility and great rapidity between these stages so that it's just much less for our clients to worry about.' Read more: 'Incredible honour': Dementia care team win prestigious award Gerry McCarron, an account manager from Scottish Enterprise, called BDD a "Scottish success story" and said the organisation is proud to support its growth and innovation. He said: 'Scottish Enterprise supports businesses to scale up through innovation and investment, with life sciences being an area where we see huge potential for high growth. 'We are backing ambitious companies like BDD Pharma to develop and deliver groundbreaking solutions to real-world problems, in high-quality labs, in turn attracting other businesses to tap into that supply chain and find their home in Scotland too. "It is fantastic to see the new facility at BioCity, which looks set to be an exciting hub for life sciences in Glasgow.'
Scotsman
3 hours ago
- Scotsman
Inclusive tech gives ‘time back to patients' amid surge in cases, says Scottish GP
A Scottish GP with dyslexia has hailed the benefits of a British-developed voice recognition tool in helping his practice cope with a rise in administrative demands and growing clinical complexity. Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Dr Mark Taylor, a family doctor of 28 years, says digital dictation software from UK medtech company Lexacom is significantly easing the admin burden on him and his colleagues at a time when GPs are under more pressure than ever. According to the Scottish Parliament Information Centre (SPICe), NHS Greater Glasgow and Clyde recorded a 1,000% increase in adult ADHD referrals between 2020 and 2023. In central Fife, referrals have risen by 500% over the past decade. Advertisement Hide Ad Advertisement Hide Ad 'We've seen a huge increase in referrals, and the wait times for specialist assessments are long,' said Dr Taylor from Kingsmills Medical Practice in Inverness, which serves around 10,000 patients and has a team of 12 clinicians. 'Using this tech has helped us focus on what matters most – time with our patients.' Lexacom Echo is helping GPs give time back to patients. 'Patient demand has changed since COVID', Dr Taylor adds. 'There are more complex cases, more paperwork, and fewer specialists to refer to. Tools like this help us to manage the work better and stay focused on care.' The software, Lexacom Echo, allows GPs to dictate directly into patient records and automatically converts medical notes into plain English, making health information easier to understand for patients. Crucially for Dr Taylor, who has dyslexia, the tool has significantly reduced the frustration of manual notetaking, improving both accuracy and continuity of care. Advertisement Hide Ad Advertisement Hide Ad He explains: 'My typing skills are poor, and making my notes clear was always a challenge. Echo helps me get my thoughts down quickly and accurately. I can't imagine a GP who wouldn't find it useful.' The use of inclusive digital tools comes as primary care practices across Scotland – and the wider UK – experience an unprecedented rise in demand for autism and ADHD assessments. National NHS data shows that more than 224,000 people were waiting for autism assessments in December 2024 – a 23% rise on the previous year and a 75% increase since 2022. These rising figures translate to a growing administrative burden on GPs, many of whom are already managing heavy caseloads and staffing shortages. Advertisement Hide Ad Advertisement Hide Ad Lexacom, the only platform offering workflow management, ambient AI, speech recognition, and digital dictation is used by more than 60% of GP practices in the UK. These tools are designed to streamline documentation, simplify patient communication, and reduce admin burden, allowing clinicians to spend more time on direct patient care. 'By reducing the time we spend writing and re-writing notes, we can increase the time spent listening to patients,' added Dr Taylor. 'In that sense, it's not just about helping the doctor – it's about giving time back to the patient.'
